Head and Neck Melanoma: Clinicopathologic Profile Is Worse Than Other Melanomas
Source: Dermatology Advisor, October 2024
Cutaneous head and neck melanoma (CHNM) has a worse clinicopathologic profile compared with cutaneous melanomas from other sites (CMOS), according to study findings published in the Journal of the American Academy of Dermatology.
Researchers analyzed data from patients treated for cutaneous nonacral melanoma at a center in Australia who were initially diagnosed from January 2000 to December 2018.
The study endpoints were locoregional control (LRC), distant metastasis-free survival (DMFS), melanoma-specific survival (MSS), and overall survival (OS) at 5, 10, and 15 years.